New patent for Astrazeneca Ab drug FARXIGA
Annual Drug Patent Expirations for FARXIGA Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from five suppliers. There are eighteen patents…
Source
Annual Drug Patent Expirations for FARXIGA Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from five suppliers. There are eighteen patents…
Source
This chart shows the pharmaceutical companies with the most cream dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most cream dosed drugs…
Source
Which pharmaceutical companies have the most cream dosed drugs? Read Post »
ABRAXANE (paclitaxel) Bristol-myers Patent: 8,314,156 Expiration: Jun 9, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
Source
Drug Patent Expirations for the Week of June 9, 2024 Read Post »
Annual Drug Patent Expirations for WELIREG Welireg is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There are two…
Source
Annual Drug Patent Expirations for WINLEVI Winlevi is a drug marketed by Sun Pharm and is included in one NDA. It is available from one supplier. There are eight patents…
Source
This chart shows the drugs with the most patents in Portugal. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
Source
Which pharmaceutical drugs have the most drug patents in Portugal? Read Post »
Sure, here’s a more detailed explanation with examples: Drug Patent Duration Drug patents are granted by the United States Patent and Trademark Office (USPTO) for a period of 20 years…
Source
Annual Drug Patent Expirations for RISVAN Risvan is a drug marketed by Labs Farms Rovi Sa and is included in one NDA. The generic ingredient in RISVAN is risperidone. Additional…
Source
Annual Drug Patent Expirations for SUNOSI Sunosi is a drug marketed by Axsome Malta and is included in one NDA. It is available from one supplier. There are twenty-eight patents…
Source
Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. It is available from two suppliers. There are eighteen patents protecting…
Source
Get new actionable insights and updates from BiotechBlog